关注
Andrew Briggs
Andrew Briggs
在 lshtm.ac.uk 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Decision modelling for health economic evaluation
A Briggs, M Sculpher, K Claxton
Oup Oxford, 2006
35952006
Consolidated health economic evaluation reporting standards (CHEERS) statement
D Husereau, M Drummond, S Petrou, C Carswell, D Moher, D Greenberg, ...
International journal of technology assessment in health care 29 (2), 117-122, 2013
29212013
Consolidated health economic evaluation reporting standards (CHEERS)—explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines good …
D Husereau, M Drummond, S Petrou, C Carswell, D Moher, D Greenberg, ...
Value in health 16 (2), 231-250, 2013
19372013
An introduction to Markov modelling for economic evaluation
A Briggs, M Sculpher
Pharmacoeconomics 13, 397-409, 1998
11471998
Modeling good research practices—overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force–1
JJ Caro, AH Briggs, U Siebert, KM Kuntz
Medical Decision Making 32 (5), 667-677, 2012
10772012
Cost‐effectiveness acceptability curves–facts, fallacies and frequently asked questions
E Fenwick, BJ O'Brien, A Briggs
Health economics 13 (5), 405-415, 2004
10012004
Handling uncertainty in cost-effectiveness models
AH Briggs
Pharmacoeconomics 17, 479-500, 2000
9592000
Pulling cost‐effectiveness analysis up by its bootstraps: a non‐parametric approach to confidence interval estimation
AH Briggs, DE Wonderling, CZ Mooney
Health economics 6 (4), 327-340, 1997
9481997
Good research practices for cost‐effectiveness analysis alongside clinical trials: the ISPOR RCT‐CEA Task Force report
S Ramsey, R Willke, A Briggs, R Brown, M Buxton, A Chawla, J Cook, ...
Value in health 8 (5), 521-533, 2005
7782005
Review of statistical methods for analysing healthcare resources and costs
B Mihaylova, A Briggs, A O'Hagan, SG Thompson
Health economics 20 (8), 897-916, 2011
7552011
A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68)
PM Clarke, AM Gray, A Briggs, AJ Farmer, P Fenn, RJ Stevens, ...
Diabetologia 47, 1747-1759, 2004
7532004
Prognosis Research Strategy (PROGRESS) 2: prognostic factor research
RD Riley, JA Hayden, EW Steyerberg, KGM Moons, K Abrams, PA Kyzas, ...
PLoS medicine 10 (2), e1001380, 2013
7452013
Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6
AH Briggs, MC Weinstein, EAL Fenwick, J Karnon, MJ Sculpher, ...
Value in Health 15 (6), 835-842, 2012
6732012
Cost-effectiveness analysis alongside clinical trials II—an ISPOR Good Research Practices Task Force report
SD Ramsey, RJ Willke, H Glick, SD Reed, F Augustovski, B Jonsson, ...
Value in health 18 (2), 161-172, 2015
6542015
Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group–6
AH Briggs, MC Weinstein, EAL Fenwick, J Karnon, MJ Sculpher, ...
Medical decision making 32 (5), 722-732, 2012
6462012
Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis
A Briggs, M Sculpher, M Buxton
Health economics 3 (2), 95-104, 1994
6361994
Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes
H Hemingway, P Croft, P Perel, JA Hayden, K Abrams, A Timmis, A Briggs, ...
Bmj 346, 2013
6172013
Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost‐effectiveness analysis
JS Hoch, AH Briggs, AR Willan
Health economics 11 (5), 415-430, 2002
5892002
Oral versus intravenous antibiotics for bone and joint infection
HK Li, I Rombach, R Zambellas, AS Walker, MA McNally, BL Atkins, ...
New England Journal of Medicine 380 (5), 425-436, 2019
5632019
The death of cost‐minimization analysis?
AH Briggs, BJ O'Brien
Health economics 10 (2), 179-184, 2001
5622001
系统目前无法执行此操作,请稍后再试。
文章 1–20